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Introduction
The Rho, Rac, and Cdc42 GTPases of the Rho protein family 
integrate environmental signals to regulate the organization and 
dynamic of the actin cytoskeleton (Burridge and Wennerberg, 
2004; Jaffe and Hall, 2005). This confers to Rho proteins a di-
rect role in controlling cell shape and adhesion, which are two 
key determinants in the regulation of the barrier function of the 
endothelium and epithelium (Wojciak-Stothard and Ridley, 
2002). Hence, the major role played by Rho proteins accounts 
for the existence of a large number of bacterial virulence factors 
targeting them (Boquet and Lemichez, 2003).
Rho proteins oscillate between a GDP-bound form se-
questered in the cytosol, in association with the cellular fac-
tor Rho guanine nucleotide dissociation inhibitor (RhoGDI; 
  DerMardirossian and Bokoch, 2005), and a GTP-bound form 
that is found in specifi  c membrane locations, which bind and 
activate effector proteins (Burridge and Wennerberg, 2004). 
Transitions between both forms of Rho are primarily regu-
lated by guanine nucleotide exchange factors for activation 
and GTPase-  activating proteins for inactivation (Burridge and 
  Wennerberg, 2004). Rho protein isoforms specifi  cally regulate 
the architecture and dynamic of the actin cytoskeleton (Burridge 
and Wennerberg, 2004; Jaffe and Hall, 2005). The activation of 
Rac or Cdc42 leads to actin fi  lament polymerization, forming 
actin-rich lamellipodia or fi  lopodia, respectively. RhoA induces 
actomyosin contraction and the formation of actin stress fi  bers 
by controlling the phosphorylation status of the myosin light 
chain (MLC). Phosphorylation of MLC is controlled by MLC 
kinases and Rho kinases (ROCKs; Katoh et al., 2001; Burridge 
and Wennerberg, 2004). Activation of ROCKs by RhoA primar-
ily leads the phosphorylation/inactivation of the regulatory sub-
unit of the myosin-specifi  c phosphatase MYPT1 (Kimura et al., 
1996). Thus, Rho regulates different aspects of the organization 
of the actin cytoskeleton in differentiated cells that impact their 
morphology, as well as both intercellular and cell–matrix adhe-
sion (Burridge and Wennerberg, 2004; Jaffe and Hall, 2005). 
For instance, the activation of Rho by vasoactive factors such as 
thrombin induces actomyosin contractions that are responsible, 
in part, for destabilizing the endothelial intercellular   junctions 
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T
he GTPase RhoA is a major regulator of the assembly 
of actin stress ﬁ  bers and the contractility of the acto-
myosin cytoskeleton. The epidermal cell differentiation 
inhibitor (EDIN) and EDIN-like ADP-  ribosyltransferases of 
Staphylococcus aureus catalyze the inactivation of RhoA, 
producing actin cable disruption. We report that puriﬁ  ed 
recombinant EDIN and EDIN-producing S. aureus provoke 
large transcellular tunnels in endothelial cells that we have 
named macroapertures (MAs). These structures open tran-
siently, followed by the appearance of actin-  containing 
membrane waves extending over the aperture.   Disruption 
of actin cables, either directly or indirectly, through rhoA 
RNAi knockdown also triggers the formation of MAs. 
  Intoxication of endothelial monolayers by EDIN produces 
a loss of barrier function and provides direct access of the 
endothelium basement membrane to S. aureus.
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and promoting the formation of intercellular gaps through 
cell contraction ( Wojciak-Stothard and Ridley, 2002). Hence, 
recent fi  ndings indicate that Rho proteins of endothelial cells 
participate in leukocyte transmigration across the endothelium 
(Carman and Springer, 2004; Millan and Ridley, 2005). In co-
lumnar epithelial cells, Rho promotes the formation of actin 
fi  laments associated with apical tight junctions and in so doing 
contributes to epithelium cohesion (Nusrat et al., 1995).
Staphylococcus aureus epidermal cell differentiation inhib-
itor (EDIN; Sugai et al., 1990) and EDIN-like factors (  Aktories 
et al., 2004) belong to a family of ADP-ribosyltransferases that are 
expressed both by human and animal Gram-  positive pathogenic 
bacteria (Aktories et al., 2004). They consist of a single polypep-
tide chain, which penetrates host cells by an undefi  ned molecular 
mechanism. Upon reaching the host cell cytosol, these factors 
catalyze the preferential ADP-ribosylation of RhoA (Chardin 
et al., 1989; Aktories et al., 2004) and, to a lesser extent, other 
isoforms of Rho proteins (Wilde et al., 2003).   Posttranslational 
modifi  cation of Rho by ADP-  ribosylation leads to the tight as-
sociation of RhoA with RhoGDI, leading to Rho sequestration 
into the cytosol (Fujihara et al., 1997; Genth et al., 2003). In ad-
dition, ADP-ribosylation blocks RhoA activation by the guanine 
nucleotide exchange factor lbc (Aktories et al., 2004). The in-
hibitory effects of RhoA ADP-  ribosylation by EDIN-like factors 
lead to the disruption of actin stress fi  bers (Chardin et al., 1989; 
Paterson et al., 1990;   Aktories et al., 2004).
Major progress has been made in understanding how bac-
terial Rho ADP-ribosylating factors interfere with immune cells 
(Caron and Hall, 1998; Aktories et al., 2004). To gain more insights 
on the biological activity of EDIN-like factors, we have investi-
gated the effects of purifi  ed recombinant EDIN, as well as EDIN-
producing S. aureus, on endothelial cells and on the endothelium.
Figure 1.  EDIN induces the formation of tran-
sient MAs. (a) Actin cytoskeleton disruption and 
MA formation in HUVECs intoxicated for 24 h 
with 100 μg/ml of EDIN. The actin cytoskeleton 
was visualized using TRITC-conjugated phalloidin. 
(b) Visualization of MAs (arrows) by scanning 
electron microscopy. Inset shows a lamellipodia-
like structure extending from the edge of a MA 
(  arrowhead). HUVECs were intoxicated for 24 h 
with 100 μg/ml of EDIN. (c) Time-lapse video 
microscopy of HUVECs intoxicated with 100 μg/ml 
of EDIN showing MA opening and closure 
  (arrows; images selected from Video 1; intervals 
in minutes). (d) Induction of MAs in different cell 
types intoxicated for 24 h with 100 μg/ml of 
EDIN. The primary human cells used were HM-
VECs and ﬁ   broblasts. The cell lines used were 
osteosarcoma-derived epithelial Saos-2 cells and 
myoblast L6 cells. The actin cytoskeleton was visu-
alized using FITC- or TRITC-conjugated phalloidin. 
Color balance was adjusted in red. Video 1 is 
available at http://www.jcb.org/cgi/content/
full/jcb.200509009/DC1. Bars, 10 μm.RHOA ADP-RIBOSYLATION PRODUCES MACROAPERTURES • BOYER ET AL.  811
Results
Rho ADP-ribosylation induces transient 
macroapertures (MAs)
We have observed that intoxication of human umbilical vein 
endothelial cells (HUVECs) with purifi  ed recombinant EDIN 
results in the formation of large transcellular tunnels that we 
have named MAs, in addition to the previously described dislo-
cation of actin stress fi  bers (Fig. 1, a and b; Chardin et al., 1989; 
Paterson et al., 1990). We noticed the presence of membranes 
extending from the edge of MAs (Fig. 1 b, inset, arrowhead). 
Analysis of the intoxication of HUVECs by EDIN, using time-
lapse video microscopy, revealed the transient nature of MAs 
(Fig. 1 c; and Video 1, available at http://www.jcb.org/cgi/ 
content/full/jcb.200509009/DC1). Complete cycles of MA 
opening and closure took 2–20 min, with a mean time of 12 min 
(n = 45 MAs, at 24 h of intoxication). In contrast, no MAs were 
observed in control HUVECs. EDIN also produced MAs in 
other potential targets of S. aureus, such as primary human 
  microvascular endothelial cells and fi  broblasts, as well as the 
myoblast and osteoblast cell lines L6 and Saos-2, respectively 
(Fig. 1 d). A low occurrence of MAs was observed in EDIN-
treated human keratinocytes and columnar epithelial T84 sub-
confl  uent cells (MAs ≤ 2% at 48 h; unpublished data).
We next investigated the characteristics of MA induction 
by EDIN in subconfl  uent endothelial cells. MAs were detected 
3 h after cell intoxication and progressively affected 33% of 
the cell population after 24 h of intoxication (Fig. 2 a). The ef-
fi  ciency of MA formation was compared with that of Rho 
ADP-ribosylation, as well as inhibition of Rho activity. Cor-
relative analysis of these kinetics indicated that MAs induced 
by EDIN began 3 h postintoxication concomitantly with ADP-
  ribosylation of 75% of endogenous Rho and 58.2% inhibition 
of Rho activity (Fig. 2 a). In further studying this newly de-
scribed effect of EDIN, we determined that the number of cells 
displaying MAs increases as a function of the concentration of 
EDIN (Fig. 2 b). Previous studies had shown that cells recover 
their actin stress fi  bers upon Rho resynthesis, which occurs af-
ter Rho ADP- ribosylating toxin clearing (Aktories et al., 2004). 
Consistently, we also observed that endothelial cells recovered 
their initial status within 48 h after EDIN clearing (Fig. 2 c). 
Induction of MAs by EDIN is, thus, a time- and dose-depen-
dent phenomenon. In addition, no effect was observed with the 
catalytically inactive EDINR185E mutant (Fig. 2 d; Menetrey 
et al., 2002). Further analyzing these aspects on endothelial 
cells transfected with either EDIN or EDINR185E expression 
plasmids, we observed a disruption of actin cables and the for-
mation of MAs, specifi   cally in cells expressing functional 
EDIN (Fig. 2 e). This allowed us to establish, after cell fi  xation 
and actin cytoskeleton staining, that 24 h of expression of 
EDIN leads to a loss of actin cables in 91% of the cells and 
formation of MAs in 49% of these cells (n = 200). Thus, con-
sistent with the transient formation of MAs, which was ob-
served using video microscopy, after cell fi  xation we found 
Figure 2.  Characteristics of EDIN-induced 
  actin-cable disruption and MA formation in 
endothelial cells. (a) Efﬁ  ciency of MA induction 
in HUVECs, as compared with ADP-ribosyl-
ation and inactivation of Rho. Histogram rep-
resents the percentage of HUVECs displaying 
at least one MA. Mean values ± SD. n = 3. 
Cells were cultured in subconﬂ  uent conditions 
and intoxicated with 100 μg/ml of EDIN 
during the indicated periods of time. Levels 
of cellular ADP-ribosylated Rho (ADPr-Rho) 
were determined by in vitro ADP-ribosylation. 
  Percentages represent the quenching of in 
vitro ADP-ribosylated Rho assessed at the in-
dicated periods of cell intoxication by EDIN. 
Mean values ± SD. n  = 3. Immunosignals 
of active Rho were normalized on total Rho 
and expressed as a percentage of active Rho 
compared with the control t = 0. Mean val-
ues ± SD. n = 3. (b and c) Percentages of 
  HUVECs displaying at least one MA or devoid 
of actin cables.   Percentages were determined 
on TRITC-  phalloidin–labeled cells in three inde-
pendent experiments and expressed as mean 
values ± SD. Subconﬂ   uent cells were intoxi-
cated either with the indicated doses of EDIN 
for 24 h (b) or were intoxicated for 24 h be-
fore EDIN clearing (t = 0; c). (d and e) Plasma 
membrane of HUVECs was visualized using 
FITC-conjugated WGA. Actin cytoskeleton 
(actin) was visualized using either TRITC- (d) or 
FITC-conjugated (e) phalloidin. (d) HUVECs 
  intoxicated for 24 h with 100 μg/ml of either 
EDIN or EDINR185E. (e) HUVECs transfected 
with either pEDIN or pEDINR185E for 16 h. 
Coexpression of nucleus-targeted DsRed was 
used to label transfected cells. Bars, 10 μm.JCB • VOLUME 173 • NUMBER 5 • 2006  812
that a maximal effect of EDIN produces MAs that are visible 
in nearly half of HUVECs.
Using video microscopy, we next analyzed the forma-
tion of MAs in cells transfected with EDIN together with 
GFP-  caveolin1. Plasma membrane was labeled with TRITC-
  conjugated wheat germ agglutinin (WGA). MAs induced by 
EDIN appeared to result from the enlargement of a pore as-
sociated with the formation of retraction fi  laments (Fig. 3 a; 
and Video 2, available at http://www.jcb.org/cgi/content/full/
jcb.200509009/DC1). Membrane retraction produces a local 
and transient accumulation of GFP-caveolin1 at the edge of the 
aperture. Rho ADP-ribosylation factors have been extensively 
studied using cell lines displaying thick actin cables, such as 
VERO cells. We noticed the formation of curved membrane 
“retractions” in VERO cells expressing EDIN (Fig. 3 b, arrows), 
which appeared to occur at the cell periphery (Video 3). Thus, 
at the difference with HUVECs in which EDIN induced MAs in 
VERO cells, membrane retractions occur at the edges of cells, 
leading to cellular retractions. We next investigated whether 
MAs were initiated by membrane ruptures. Induction of mem-
brane wounding by pathogens or mechanical stress leads to 
lysosomal exocytosis for membrane repair (Roy et al., 2004). 
In contrast with what was reported for wounded cells (Huynh 
et al., 2004), the lysosomal marker Lamp1 was not detected at 
the cell surface of EDIN-intoxicated cells (Fig. 3c). Finally, we 
observed that membrane waves, which formed at the edge of 
apertures, contained Rac, cortactin, and Arp3 machinery of ac-
tin polymerization (Fig. 3 d), as observed in membrane ruffl  es 
(Weed et al., 1998).
MAs result from RhoA inhibition and actin 
stress ﬁ  ber disruption
EDIN and other isoforms of the C3 exoenzyme family ADP-
  ribosylate RhoA and, to a lesser extent, different combinations 
of other Rho proteins (Wilde et al., 2003). For this reason, we 
examined the effects of expression of three other members of 
the C3 exoenzyme family, i.e., EDIN-B and -C of S. aureus, as 
well as the C3 exoenzyme of Clostridium botulinum.  Expression 
of these isoforms of C3 exoenzyme also induced the formation 
of MAs (Fig. 4 a), in contrast with catalytically inactive mu-
tants (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200509009/DC1). MAs produced by C3 exoenzyme of 
C. botulinum also formed transiently (Video 4). Collectively, 
these results suggested that RhoA inhibition may account for 
Figure 3.  Visualization of MA formation. (a) 
Formation of MAs (arrows) in HUVECs cotrans-
fected with GFP-caveolin1 and EDIN expression 
  plasmids. Plasma membrane was labeled for 1 h 
with 20 μg/ml TRITC-conjugated WGA (images 
  selected from Video 2; intervals in minutes).   Contrast 
and color balance were adjusted. (b) Actin 
  cytoskeleton disruption and cell retraction (arrows)
in VERO cells cotransfected with pEDIN and 
pDsRed2 nucleus (red). Actin cytoskeleton was visu-
alized using FITC-conjugated phalloidin (green). 
(c) Lysosomal exocytosis were visualized by anti-
Lamp1 immunolabeling on HUVECs control, intox-
icated for 24 h with 100 μg/ml of EDIN (EDIN), 
or wounded by electroporation at 300 V, 450 μF 
(wounded), as previously described (Huynh 
et al., 2004). Graph represents the percentage 
of Lamp1-positive cells. n > 400 cells/condition. 
(d) Localization of Rac, cortactin, Arp3, and actin 
in membrane rufﬂ  es extending from the edges of 
MAs (arrows). HUVECs were cotransfected with 
pEDIN and pEGFP (not depicted). Cells were pro-
cessed for immunolabeling 16 h after transfection. 
Video 2 is available at http://www.jcb.org/cgi/
content/full/jcb.200509009/DC1. Bars, 10 μm.RHOA ADP-RIBOSYLATION PRODUCES MACROAPERTURES • BOYER ET AL.  813
a   general mechanism by which MAs are produced. To address 
this question we knocked down RhoA using RNA interference. 
The cellular depletion of RhoA was quantifi  ed by immunoblot-
ting, and its level was found to decrease to 25% within 24 h after 
cell transfection (Fig. 4 b). Under these conditions, we observed 
that 24 h after transfection of a rhoA RNAi expression plasmid, 
endothelial cells displayed MAs and a disruption of actin cables 
(Fig. 4 c). The effects of RNAi-mediated RhoA knockdown on 
the dynamic of the actin cytoskeleton was further analyzed in 
endothelial cells expressing a GFP-actin chimeric molecule. In 
control cells, the GFP-actin signal shows actin cables and corti-
cal actin cytoskeleton (Fig. S2 a). In endothelial cells cotrans-
fected with rhoA RNAi and GFP-actin expression plasmids, 
MA formation appeared to be rapidly followed by the recruit-
ment of GFP-actin around the aperture (Fig. 4 d; Video 5). 
GFP-actin next concentrated into lamellipodia-like structures 
extending from the edge of the aperture. The absence of effects 
of control RNAi on the actin cytoskeleton was verifi  ed (Fig. 
S2 b). The dynamics of the actin cytoskeleton during a cycle 
of MA formation by EDIN appeared similar to those observed 
after RNAi-mediated RhoA knockdown (Video 6). Collectively, 
this demonstrated that RNAi-mediated RhoA knockdown reca-
pitulated the effects of EDIN, resulting in transient formation 
of MAs in endothelial cells. Our results favor the hypothesis 
that the destruction of cytosolic actin cables after RhoA inhi-
bition leads to the formation of MAs. To test this hypothesis, 
HUVECs were treated with different drugs that destabilize 
the actin cytoskeleton, using mild conditions to minimize cell 
  retractions. Under these conditions, MAs were observed upon 
cell treatment with cytochalasin D and latrunculin B, as well as 
with the ROCK inhibitor Y-27632 (Fig. 4 e). Finally, we verifi  ed 
that Y-27632 did not produce RhoA inhibition (not depicted), 
Figure 4.  Inhibition of RhoA or actin stress 
  ﬁ   ber disruption induce MAs in endothe-
lial cells. (a–c) HUVEC plasma membrane 
or actin cytoskeleton were visualized using 
FITC-conjugated WGA or FITC-conjugated 
phalloidin (actin),   respectively. Coexpression 
of nucleus-targeted DsRed was used to label 
transfected cells. (a) HUVECs transfected with 
either pEF-C3,   pEDIN-B, or -C. (b) Immunob-
lots showing the depletion of RhoA induced 
by RNAi-mediated RhoA knockdown. Cells 
were cotransfected with plasmids expressing 
either  rhoA  RNAi or rhoA-scrambled  RNAi 
(control) together with pEGFP for transfec-
tion level normalization. (c) Cellular effects of 
RNAi-mediated RhoA knockdown 16 h after 
HUVECs transfection. Cells were transfected 
with either rhoA RNAi or control RNAi expres-
sion plasmids. (d)   HUVECs cotransfected with 
GFP-actin and rhoA RNAi expression plasmids 
(images from video 6; intervals in seconds). 
(e) Formation of MAs (arrows) in subconﬂ  uent 
  HUVECs treated for 7 h with 50 μM Y-27632 
or 40 ng/ml latrunculin B and for 24 h with 
either 20 ng/ml cytochalasin D or 100 μg/ml 
EDIN. Efﬁ   ciencies of MA formation were 
  assessed on phalloidin-labeled cells, giving 
1% for latrunculin B and cytochalasin D and 
11.3% for Y-27632. n = 300 cells; two inde-
pendent experiments.   Actin cytoskeleton was 
visualized using FITC- or TRITC-conjugated 
phalloidin. Color balance was adjusted in 
red. (f) Effects of RhoGDI expression on actin 
cytoskeleton and cell morphology. HUVECs 
were cotransfected with 5 μg pRhoGDI and 
10  μg pEGFP-C1. Actin cytoskeleton was 
  visualized using TRITC-conjugated phalloidin, 
6 h after cell transfection. Video 6 is avail-
able at http://www.jcb.org/cgi/content/full/
jcb.200509009/DC1. Bars, 10 μm.JCB • VOLUME 173 • NUMBER 5 • 2006  814
but, instead, dynamic MAs similar to those produced by EDIN 
(Fig. S2 c). In addition, we observed that the overexpression of 
the Rho-family inhibitor RhoGDI produced cellular retractions 
instead of MAs (Fig. 4 f), as does the RhoA, Rac, and Cdc42 
inhibitory toxin-B of Clostridium diffi  cile (Video 7; Just et al., 
1995). In conclusion, we show that the preferential inhibition 
of RhoA by EDIN and the disruption of RhoA-regulated actin 
cytoskeleton account for MA formation.
Formation of MAs in endothelial cell 
monolayers and endothelium
We next investigated MA induction by EDIN in endothelial cell 
monolayers. Intercellular junctions were visualized by staining 
VE-cadherin, which is a major component of endothelial ad-
herens junctions (Fig. 5 a; Bazzoni and Dejana, 2004). When 
HUVECs were engaged in intercellular junctions, we measured 
a 20% higher level of active Rho, as compared with that mea-
sured in subconfl  uent cells (n = 3, mean value). Under these 
conditions, we measured that the level of active Rho dropped to 
0.2% of total Rho at 48 h, a value similar to that obtained with 
subconfl  uent cells intoxicated for 24 h (Fig. 5 b). In   HUVEC 
monolayers, at 48 h of intoxication by EDIN we measured 
that 5.9 ± 0.5% (n = 400 cells) of cells displayed MAs (Fig. 
5 c). MAs were also observed in human microvascular endo-
thelial cell (HMVEC) monolayers that were intoxicated for 
48 h in similar conditions (Fig. 5 d; 6.9 ± 1%; n = 300 cells). 
In contrast, no MAs were observed in HUVEC and HMVEC 
monolayers treated with EDINR185E (unpublished data). Similar 
results were obtained with the C3 exoenzyme of C. botulinum 
(unpublished data). The VE-cadherin signal was not detected 
at the edge of MAs (Fig. 5, a and d; and Video 8, available at 
http://www.jcb.org/cgi/content/full/jcb.200509009/DC1). MAs 
also formed transiently in monolayers (Videos 8 and 9). We next 
investigated the effects of EDIN on endothelial monolayer bar-
rier function. Previous studies had established that RhoA activa-
tion by vasoactive factors, such as thrombin, leads to stress fi  ber 
formation and actomyosin contractions, which are responsible 
for intercellular gaps opening (Essler et al., 1998;   Carbajal and 
Schaeffer, 1999; Wojciak-Stothard et al., 2001). These effects 
of thrombin are blocked by C3 exoenzyme.   Consistent with 
Figure 5.  Effect of EDIN on endothelial monolayers. 
(a) Disruption of actin stress ﬁ  bers and formation of MAs in 
HUVECs monolayers intoxicated with 100 μg/ml of EDIN 
during the indicated periods of time. Monolayers were 
  labeled with FITC-phalloidin (actin), together with anti-
  cadherin5 (VE-cadherin). Arrows indicate MA location. (b) 
Levels of active Rho were determined by GST-rhotekin RBD 
pull-down assay. Values of active Rho are expressed by 
comparison with the signal obtained with 2% of total Rho; 
t = 0. Mean values ± SD. n = 3. (c) Percentages of 
  HUVECs displaying at least one MA were determined on 
FITC-phalloidin–labeled cells in two independent experi-
ments and expressed as mean values ± SD. (d) Effect of 
EDIN on HMVEC monolayers, as described in a. (e) Effects 
of EDIN and EDINR185E on endothelial monolayer barrier 
function were assessed at the indicated periods of time, by 
determining quantities of ﬂ   ow through of FITC-BSA from 
the top to bottom chamber. Graph represents percentages 
of variation of permeability, as compared with t = 0 of 
each monolayer. Mean ± SD. n = 4. Bars, 10 μm.RHOA ADP-RIBOSYLATION PRODUCES MACROAPERTURES • BOYER ET AL.  815
 previous fi  ndings, we measured that short periods of intoxication 
by EDIN or C3 exoenzyme effi  ciently blocked the thrombin-
induced activation of RhoA, the formation of intercellular gaps 
and an increase of monolayer permeability, whereas it did not 
effi   ciently inhibit the level of active-Rho (Fig. S3). Longer 
  periods of intoxication were necessary to lower the level of ac-
tive Rho required to produce MAs and to compromise mono-
layer barrier function (Fig. 5, b and e).
Collectively, our results were indicative of a role of EDIN 
in producing MAs in the endothelium. We addressed this ques-
tion by analyzing the effects produced by purifi  ed recombinant 
EDIN on the endothelium of rat arteries. The lumenal surface of 
arteries was analyzed by scanning electron microscopy 7 h after 
intoxication with either purifi  ed recombinant EDIN or with the 
catalytic-inactive mutant EDINR185E (Fig. 6). We specifi  cally 
observed MAs at the surface of the endothelium of EDIN-
  intoxicated arteries (Fig. 6, a and b). EDIN-intoxicated arteries 
had 400 ± 50 MAs/mm
2 at their surface. Consistent with our 
observations of endothelial cells, we observed a high heteroge-
neity of the size of these MAs with a mean value of 7 ± 3 μm 
(n = 50 MAs, at 7 h of intoxication). MAs were found to un-
mask the fi  brous structure of the extracellular matrix visualized 
underneath the endothelium (Fig. 6 c). In parallel, we observed 
by transmission electron microscopy that EDIN disrupted the 
endothelial cell layer integrity (Fig. 6 d). Finally, investigating 
the effects of Rho ADP-ribosylating toxins on vascular permea-
bility using a classical Evans blue dye extravasation assay in 
mice, we found that EDIN and C3 exoenzyme induced dye dif-
fusion (Fig. 6 e; and Fig. S3, d and e). Collectively, our results 
show that Rho inactivation produces MAs in the endothelium 
and compromises the endothelium barrier function.
S. aureus producing EDIN get access 
to the endothelial basement membrane
We next addressed the question of whether the effects of EDIN 
might confer to S. aureus a physical mechanism by which the 
endothelium basement membrane is exposed to the bacteria. 
To address this question, S. aureus S25-edin
− and -edin
+ strains 
Figure 6.  MA formation on aortic endothe-
lium induced by EDIN. (a–d) Rat aortic arteries 
were intoxicated for 7 h with 200 μg/ml of 
either EDIN or EDINR185E. MAs at the surface 
of the endothelium were visualized by scan-
ning electron microscopy using lower detec-
tor conditions SEI (a–c) and by transmission 
electron microscopy (d). (c) Formation of MAs 
unmasks the ﬁ   brous structure of endothelial 
cell adhesive matrix molecules. (d) Section 
of intoxicated arteries analyzed by transmis-
sion electron microscopy. (e) Quantiﬁ  cation 
of the effects of C3 exoenzyme (C3) on vas-
cular extravasation of Evans blue dye in ears 
(one representative experiment out of three). 
Groups of mice had either wild-type EDIN or 
mutated EDINRE injected into the tail vein 36 h 
before Evans blue injection. Graph represents 
OD600 values of Evans blue dye extracted and 
normalized to tissue weight (each circle corre-
sponds to one ear). Red lines correspond to 
mean values. P < 0.006, t test. Bars: (a–c) 
10 μm; (d) 1 μm.JCB • VOLUME 173 • NUMBER 5 • 2006  816
were engineered from the EDIN-producing human pathogenic 
strain S25. We verifi   ed in these strains the presence of an 
EDIN-encoding gene, as well as the RhoA ADP-ribosylation 
activity (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200509009/DC1). After MA formation in HUVECs 
that were infected by these different strains of S. aureus, we 
determined that EDIN was specifi  cally required for actin stress 
fi  ber disruption and MA induction (Fig. 7 a). The transient 
formation of MAs in HUVECs infected by wild-type S25 was 
also verifi  ed (Video 10). We went on to determine the biologi-
cal effects of EDIN on the endothelium of rat arteries infected 
by S. aureus. We observed that both wild-type S25 and S25-
edin
+ strains, in contrast to S25-edin
−, produced MAs in the 
endothelium (Fig. 7 b). The surface of the endothelium also ap-
peared smoother after infection by EDIN-producing S.   aureus. 
Consistent with our hypothesis, EDIN-producing bacteria were
observed in close proximity to the endothelium basement 
  membrane (Fig. 7 c).
Discussion
We report that inactivation of RhoA, either by ADP-  ribosylating 
factors or by cellular depletion, leads to the formation of large 
and transient transcellular tunnels within endothelial cells that 
we have named MAs. We show that these structures compro-
mise the integrity of the endothelium barrier.
The observation that EDIN induces both actin cable 
  disruption and a formation of MAs favor a scenario in which the 
specifi  c inactivation of RhoA by EDIN fi  rst leads to actin cable 
disruption, which in turn allows formation of transcellular MAs. 
Consistently, we show that MAs are formed through RhoA 
  depletion by RNAi knockdown and ROCK inhibition, as well 
as actin fi  lament disassembly with cytochalasin D and latrun-
culin B. EDIN did not affect the levels of active Rac or Cdc42 
 (un published data). The importance of the specifi  city of RhoA 
inhibition in inducing the formation of MAs is reinforced by the 
observation that inhibitors that affect several Rho proteins, such 
as RhoGDI or C. diffi  cile toxin-B, produced cell retractions in-
stead of MAs. We have noticed that high concentrations of the 
ROCK inhibitory molecule Y-27632 are required to produce 
MAs. Thus, we cannot exclude the implication of other RhoA-
regulated pathways in EDIN-induced MA formation. One likely 
hypothesis is that destruction of thin actin stress fi  bers through 
inactivation of the RhoA–mDIA pathway contributes to MA 
formation (Watanabe et al., 1999). We demonstrate that EDIN 
produces a specifi  c destruction of the actin cytoskeleton net-
work regulated by RhoA, which accounts for the formation of 
MAs in endothelial cells.
One question, which remains to be addressed, concerns the 
initial membrane events leading to the formation of MAs. One 
hypothesis is that MAs are initiated by ruptures of the plasma 
membrane. This is unlikely, considering that EDIN did not trig-
ger Lamp1 localization at the plasma membrane like membrane 
wounding does (Huynh et al., 2004). Alternatively, formation of 
MAs could be caused by either a fusion of vesicles and/or plasma 
membranes or to the enlargement of a preexisting pore. In line 
with this last hypothesis, endothelial cells are extremely thin and 
are rich in interconnected vesicles referred to as vesiculo-vacuolar 
organelles (VVO), which provide a route of extravasation of 
macromolecules that is induced by the vascular permeability 
factor VEGF, for example (for review see Dvorak and Feng, 
2001). Formation of MAs through enlargement of VVO struc-
tures seems unlikely, considering that cotreatment of EDIN-
  intoxicated endothelial cells with VEGF did not increase the rate 
of MA formation (unpublished data), and that MAs form in cell 
types other than endothelial cells. Finally, it is possible that 
MAs initiate through luminal and abluminal membrane fusion. 
  Notably, plasma membrane fusions occur during daughter cell 
partitioning, which is a biological phenomenon in which the 
completion of cytokinesis may require the down-regulation of 
RhoA (Jantsch-Plunger et al., 2000). Bridging luminal and 
Figure 7.  EDIN-producing  S. aureus induces MAs in endothelial cells. 
(a) Visualization of the actin cytoskeleton and bacteria using TRITC-conjugated 
phalloidin and rabbit serum anti–S. aureus (green), respectively. HUVECs 
were infected for 1 h with S25, S25-edin
+, or -edin
− strains of S. aureus at 
a MOI of 100. (b) Lumenal surface of infected arteries visualized by scan-
ning electron microscopy. Rat aortic arteries were infected for 1 h with 
S25, S25-edin
+, or -edin
− strains of S. aureus at 10
6 bacteria/ml. Scan-
ning electron microscopy pictures were acquired using the microscope’s 
lower detector conditions. (c) Transmission electron microscopy picture 
showing EDIN-producing S. aureus located in contact with the endothelium 
basement membrane. Rat aortic arteries were infected for 1 h with 10
6 
wild-type S25 bacteria/ml. Bars: (a and b) 10 μm; (c) 1 μm.RHOA ADP-RIBOSYLATION PRODUCES MACROAPERTURES • BOYER ET AL.  817
  abluminal plasma membranes might favor formation of MAs. 
In line with this latter hypothesis, high intravascular pressures lead 
to the formation of intracellular gaps in endothelial cells (Neal 
and Michel, 1996). Hence, it has been previously reported that 
RhoA ADP-ribosylation induces cell spreading, which is a phe-
nomenon that may favor the contact between luminal and ablu-
minal plasma membranes (  Carbajal and Schaeffer, 1999). In line 
with this last hypothesis, we have measured that EDIN produced 
less MAs when endothelial cells are buried in monolayers, as 
compared with subconfl  uent cells.
Different types of structures account for endothelium 
permeability (for review see Michel and Curry, 1999). Majno 
and Palade (1961) fi  rst observed that the increase in microvas-
cular permeability is achieved by formation of gaps between 
endothelial cells. Nevertheless, ultrastructural studies have 
shown that other types of gaps, which are referred to as open-
ings, pass through, rather than between, endothelial cells (Feng 
et al., 1997; Michel and Neal, 1999). Finally, recent works sug-
gest that endothelium permeability also results from the for-
mation of VVO structures, in the absence of either inter- or 
intracellular gap formation (Dvorak and Feng, 2001). RhoA 
activation and the downstream contraction of the actin cyto-
skeleton has been recognized as a central element of intercel-
lular gap formation in response to vasoactive mediators such 
as thrombin (Essler et al., 1998; Carbajal and Schaeffer, 1999; 
  Wojciak-  Stothard and   Ridley, 2002). Consistent with this no-
tion, blocking the thrombin-induced activation of RhoA using 
Rho ADP-  ribosylating C3 exoenzyme impairs the increase of 
endothelial monolayer permeability (Wojciak-Stothard et al., 
2001). We report that a higher threshold of inactivation of 
RhoA allows MA formation in endothelial cells and impacts 
endothelial monolayer barrier function. Collectively, these 
fi  ndings point to the activation or inactivation of RhoA, lead-
ing to either inter- or intracellular gap formation. The relative 
contribution of inter- and intracellular gaps in the regulation 
of the endothelium permeability is under debate (Michel and 
Neal, 1999). One hypothesis is that the formation of MAs rep-
resents a favorable pathway for infl  ammatory cell emigration 
from the blood stream. This idea is supported by the observa-
tions that infl  ammatory cells can migrate across thinner areas 
of endothelial cells that are distant from intercellular junctions 
during their extravasation from the blood stream (Feng et al., 
1997; Hoshi and Ushiki, 1999). In vitro studies indicate that 
during their diapedesis infl  ammatory cells trigger the forma-
tion of membrane projections or transmigratory cups in endo-
thelial cells (Carman and Springer, 2004; Millan and Ridley, 
2005). Transmigratory cups show similarities with the MAs 
surrounded by membrane waves induced by EDIN. In line with 
possible similarities between both phenomenons, membrane 
projections formed during leukocyte transmigration were not 
blocked upon RhoA ADP-ribosylation, whereas they were 
blocked upon inhibition of Rho proteins by C. diffi  cile toxin-B 
(Carman and Springer, 2004). Thus, it will be interesting to 
determine whether the complex crosstalk of leukocytes with 
endothelial cells triggers a local inhibition of RhoA for trans-
migratory cup formation, and whether EDIN has exploited this 
regulation to induce the formation of MAs.
Little is known concerning the role of EDIN with regard 
to human infection by S. aureus, except that pathogenic 
S. aureus have a higher prevalence of edin genes, as compared 
with nasal isolates (Czech et al., 2001). This Gram-positive bac-
terium colonizes the epithelium in 30–50% of healthy adults 
worldwide. Its ability to produce bacteremia on accidental or 
surgical wounds can lead to severe endovascular and metastatic 
infections (Lowy, 1998). Development of such serious infec-
tions requires numerous bacterial virulence factors, comprising 
microbial surface components recognizing endothelial cell–
  adhesive matrix molecules (Foster and Hook, 1998; Lowy, 
1998). The mechanism by which luminally located S. aureus 
accesses components of the endothelial cell basement mem-
brane remains an outstanding question. Based on our observa-
tions, it can be hypothesized that MA formation may provide 
EDIN-producing S. aureus with a specifi  c mechanism to induce 
a discontinuity of the endothelium barrier.
Materials and methods
DNA constructs and bacterial genetic
The DNA encoding EDIN (NCBI M63917) was cloned using EcoRI–XhoI 
into pcDNA4 (Invitrogen) after PCR ampliﬁ  cation on the E1 strain of 
S. aureus (provided by M. Sugai, Hiroshima University, Hiroshima, Japan; 
Inoue et al., 1991) using the following oligonucleotides: E1r, 5′-C  C  C  G  A  A  T-
T  C  A  T  G  A  A  A  A  A  C  A  A  A  T  T  A  C  T  T  T  T  T  A  A  A  A  T  T  T  T  T  T  T  G  -3′ and E1f, 5′-C  C  C  C  T  C  G-
A  G  C  T  A  T  T  T  T  T  T  A  A  A  A  A  C  A  A  T  A  G  C  T  G  T  T  A  T  T  A  T  G  -3′. For EDIN production, the 
DNA was cloned using BamHI–EcoRI into pET28a after PCR ampliﬁ  cation 
using oligonucleotides 5′-C  C  G  G  A  T  C  C  G  C  T  G  A  T  G  T  T  A  A  A  A  A  T  T  T  C  A  C  T  G  A  T  T-
T  A  G  -3′ and 5′ G  G  G  A  A  T  T  C  C  T  A  T  T  T  T  T  T  A  A  A  A  A  C  A  A  T  A  G  C  T  G  T  T  A  T  T  -3′. For 
  expression in S. aureus, edin was cloned using BamHI–PstI into pMK4-pPROT 
(Archambaud et al., 2005) after PCR ampliﬁ  cation using oligonucleotides 
E1r, 5′-C  C  C  G  G  A  T  C  C  A  T  G  A  A  A  A  A  C  A  A  A  T  T  A  C  T  T  T  T  T  A  A  A  A  T  T  T  T  T  T  T  G  -3′ 
and E1f, 5′-CCCCTGCAGC  T  A  T  T  T  T  T  T  A  A  A  A  A  C  A  A  T  A  G  C  T  G  T  T  A  T  T  A  T  G  -3′. 
Recombinant bacterial strains were generated from an EDIN-  producing 
human pathogenic strain of S. aureus (labeled S25) isolated from a 
75-yr-old man with a spondylodiscitis-  associated bacteremia (P. Boquet and 
P. Dellamonica, Hôpital ARCHET II, Nice, France). The S25-edin
+ strain was 
generated by introducing the pMK4-pPROT-edin into the S25-edin
− strain 
corresponding to wild-type S25 cured of EDIN-encoding plasmid, using 
standard protocols. These strains were checked for the presence of an edin-
encoding gene (using oligonucleotides E1r and E1f), as well as for ADP-
  ribosylation activity of RhoA (Fig. S4). The pEF-C3 was used for expression 
into cells of C. botulinum C3 exoenzyme (Hill et al., 1995). The DNAs 
encoding EDIN-B (NCBI AJ277173) and EDIN-C (NCBI NC_003265) 
were isolated after PCR ampliﬁ  cation of pathogenic strains of S. aureus 
isolated at the Hospital of Nice (Nice, France; strains 7256 and Stal36, 
respectively). The DNAs of edin-B and -C were cloned using BamHI–EcoRI 
into pcDNA4 (Invitrogen) after being ampliﬁ  ed using the following oligo-
nucleotides: B, 5′-CCGGATCCA  T  G  G  C  C  G  A  G  A  C  T  A  A  A  A  A  T  T  T  T  A  C  A  G  A  C  T  T-
A  G  T  T  -3′ and 5′-GGGAATTCT  T  A  T  T  T  T  T  T  A  A  A  A  A  C  T  A  C  A  G  C  A  G  T  T  A  T  A  A  T  -3′ or 
C, 5′-G  G  G  G  A  T  C  C  A  T  G  A  A  A  A  G  A  A  A  A  T  T  A  T  T  T  T  T  T  A  A  A  A  T  T  -3′ and 5′-G  G  G  A-
A  T  T  C  T  T  A  C  T  T  T  T  T  G  A  A  A  A  C  G  A  T  A  C  C  T  T  C  G  A  T  -3′. Mutation R185E in the con-
served sequence GRPI of EDIN, and the equivalent in EDIN-B, -C, and the 
C3 exoenzyme were introduced by changing AGA into GAA (EDIN), AGG 
into GAG (EDIN-B), AGA into GAA (EDIN-C), and AAG into GAG (C3 exo-
enzyme) using the QuickChange site directed mutagenesis kit (Stratagene). 
A previously described rhoA RNAi sequence (5′-A  A  G  G  C  A  G  A  G  A  U  A  U  G  G-
C  A  A  A  C  A  -3′) or a corresponding rhoA RNAi scrambled sequence (control 
RNAi; 5′-G  A  A  G  T  G  A  C  G  A  C  A  G  G  A  C  A  A  A  T  A  -3′) were cloned in the pSIRNA 
vector (Invivogen) according to the manufacturer’s instructions. Human 
β-actin cDNA was cloned using XhoI–ApaI in pEGFP-C1 (  CLONTECH Lab-
oratories, Inc.). pCMV-RFP-actin was provided by E. Fuchs (The   Rockefeller 
University, New York, NY). Other DNA constructs used were pDsRed2-Nuc 
(CLONTECH Laboratories, Inc.), canis   Caveolin1 cloned using XhoI–BamHI 
in pEGFP-C1, rattus Lamp1 cloned using XhoI–BamHI into pEGFP-N2, hu-
man RhoGDI-α 6His-tagged cloned using BglII–PstI in pCMV (pRhoGDI), 
and VE-cadherin cloned using EcoRI–BamHI in pEGFP-N3 (provided by 
D. Gulino, Institut de Biologie Structurale Jean-Pierre Ebel, Grenoble, France).JCB • VOLUME 173 • NUMBER 5 • 2006  818
Cell culture and biochemical products
HUVECs (PromoCell) were grown in serum-free medium (SFM) supple-
mented with 20% FBS, 20 ng/ml basic FGF, 10 ng/ml EGF (Invitrogen), 
and 1 μg/ml heparin (Sigma-Aldrich). HUVECs were electroporated as 
previously described (Doye et al., 2006), using 5 μg pDsRed2-Nuc to-
gether with 10 μg of pEDIN for toxin expression. For subconﬂ  uent HUVEC 
experiments, cells were plated at 15,000 HUVECs per well in 12-well 
plates. Human primary keratinocytes and ﬁ   broblasts were provided by 
L.  Turchi (Faculté de Médecine, Nice, France). HMVECs (provided by 
A. Orecchia and G. Zambruno, Instituto Dermopatico dell’Immacolata–
  Instituto di Ricovero e Cura a Carattere Scientiﬁ  co, Rome, Italy) were iso-
lated and grown as previously described (Jackson et al., 1990). Other 
cells used were Saos-2 epithelial cells derived from osteosarcoma (HTB-85), 
L6 myoblast cells (CRL-1458), and VERO epithelial cells derived from 
  kidney (CCL-81; all from American Type Culture Collection). C3 exoen-
zyme and EDIN were puriﬁ  ed by His-tag afﬁ  nity chromatography. EDIN 
was further dialyzed against 25 mM Tris and 50 mM NaCl, and then puri-
ﬁ  ed on a CM–Sepharose fast ﬂ  ow (GE Healthcare). The antibodies used 
were monoclonal anti-RhoA, anti-Cdc42, and anti-Rac1 (BD Biosciences), 
anti-GFP (clones 7.1 and 13.1; Roche), anti–β-actin (clone AC-74; Sigma-
Aldrich), anti-cortactin (clone 4F11; Upstate Biotechnology), polyclonal 
anti-cadherin5 (Bender MedSystems), and allophycocyanin-conjugated 
anti-Lgp120/Lamp1 (clone H4A3; Abcam). Arp3 polyclonal antibodies 
were provided by P. Cossart (Institut Pasteur, Paris, France). Anti–S. aureus 
serum was raised against the E-1 strain (Sugai et al., 1990) using standard 
rabbit immunization protocols (Eurogentec). For immunoﬂ  uorescence anal-
ysis, primary antibodies were visualized using Texas red–conjugated anti–
mouse antibodies (Vector Laboratories), Texas red–conjugated anti–rabbit 
antibodies (Jackson ImmunoResearch Laboratories), or FITC-conjugated 
anti–rabbit antibodies (Biosys). For immunoblotting, primary antibodies 
were visualized using goat anti–mouse or anti–rabbit horseradish peroxi-
dase–conjugated secondary antibodies (DakoCytomation), followed by 
chemiluminescence detection ECL (GE Healthcare). Biochemical products 
were purchased from Sigma-Aldrich, with the exception of latrunculin B 
and cytochalasin D (Calbiochem). The toxin-B of C. difﬁ  cile was provided 
by I. Just (Hannover Medical School, Hannover, Germany).
Transendothelial and in vivo permeability assays
For permeability assays, HUVECs were grown on gelatin-coated polyester 
ﬁ  lters (3-μm pore size; 12-mm diam; Greiner Bio-One). Cells were plated 
at 2 × 10
5 cells/well and grown for 4 d in supplemented SFM. For intoxi-
cation, HUVEC monolayers were treated with 100 μg/ml of EDIN or 
  EDINR185E in supplemented SFM. For thrombin treatment, monolayers were 
incubated 1 h with thrombin 1 U/ml in SFM. Variations of permeability of 
each monolayer were followed at different periods of time (0, 24, and 
48 h). In brief, at each time point the medium in the top chamber was re-
placed by supplemented SFM containing 0.5 mg/ml FITC-BSA (Invitrogen). 
Samples were collected after 10 min in the bottom compartments. 
  Monolayers were washed once and incubated again in supplemented SFM 
containing toxin up to the next measurements. Levels of FITC-BSA in the bot-
tom chamber were determined with a ﬂ  uoroscan Ascent (Thermolab Sys-
tem), using an excitation wavelength of 485 nm, and detecting emission at 
538 nm. Animal vascular permeability was assessed using a classical 
  Evans blue dye extravasation assay. Groups of 6-wk-old BALB/c mice were 
injected into the tail vein three times at 12 h intervals, with 5 or 10 mg of 
toxins/Kg (for C3 or EDIN). Evans blue dye (30 mg/Kg in 100 μl PBS; 
Sigma-  Aldrich) was injected into the tail vein 36 h after the ﬁ  rst injection, 
and the Evans blue dye was extracted 1 h later from ears and quantiﬁ  ed, 
as previously described (Han et al., 2002). Animals used during this study 
were maintained and handled according to the regulations of the European 
Union and the French Department of Health and Agriculture.
Microscopy techniques and video imaging
Immunoﬂ  uorescence studies were performed on cells ﬁ  xed in 4% parafor-
maldehyde (Sigma-Aldrich). The actin cytoskeleton was labeled using 
1 μg/ml FITC- or TRITC-conjugated phalloidin (Sigma-Aldrich). For plasma 
membrane labeling, intact cells were incubated with 20 μg/ml FITC-
  conjugated WGA (Sigma-Aldrich) at 4°C before ﬁ  xation. Immunosignals 
were analyzed with a confocal microscope (TCS-SP; Leica) with a 63× 
magniﬁ  cation lens. Each picture represents the projection of four serial con-
focal sections. Cells were analyzed by video microscopy on an Axiovert 
200 microscope equipped with shutter-controlled illumination (Carl Zeiss 
MicroImaging, Inc.) and a cooled digital charge-coupled device camera 
(Roper Scientiﬁ  c). Images were processed using MetaMorph 2.0 image 
analysis software (Invitrogen) and QuickTime pro 7 software (Apple).
For electron microscopy, 6–8 wk old male Wistar rats (150–200 g; 
Janvier Laboratories) were anesthetized with pentobarbital (30 mg/kg i.p.) 
and ketamine (100 mg/kg i.p.) before i.v. injection of 10 mg/kg heparin 
(Sigma-Aldrich). 5-mm-long aortic arches were excised and rinsed in 
  Celsior medium (Imtix-Sangstat) supplemented with 0.1% wt/vol heparin. 
Arteries were incubated for 7 h at 37°C in Celsior supplemented with 
0.2 μg/ml of puriﬁ   ed recombinant EDIN or EDINR185E or for 1 h with 
S. aureus strains. Samples were removed and immersed in 1.5% glutaralde-
hyde in 100 mM phosphate buffer, pH 7.4, for at least 18 h at 4°C, and 
then processed in parallel for transmission electron microscopy (CM12; 
Philips) and scanning electron microscopy (6340F; Jeol), using standard 
techniques (Arnold and Boor, 1986). Animals used during this study were 
maintained and handled according to the regulations of the European 
Union and the French Department of Health and Agriculture.
Biochemical assays
For ADP-ribosylation assays, control or intoxicated HUVECs (10
7 cells/time 
point) were homogenized in 0.25 ml cold BSI buffer (3 mM imidazole, pH 
7.4, and 250 mM sucrose) supplemented extemporaneously with 1 mM 
phenylmethylsulfonyl ﬂ  uoride. Cells were lysed by passing 40 times through 
a 1-ml syringe equipped with a 25G × 5/8” needle (U-100 Insulin; Terumo 
Medical Corporation). Nuclei were removed by centrifugation for 10 min 
at 10,000 g at 4°C. Protein concentrations of the postnuclear supernatants 
were determined using DC protein assay (Bio-Rad Laboratories). ADP-
  ribosylations were performed for 30 min at 37°C on 10 μg of intoxicated 
cell lysates supplemented with 0.5 μCi [
32P]NAD (800 Ci/mmol) and 1 μg 
of EDIN. Levels of active Rho were determined by GST-rhotekin RBD pull-
down that was modiﬁ  ed as described previously (Doye et al., 2002).
Online supplemental material
Fig. S1 shows actin cytoskeleton disruption and MA formation by EDIN-
isoforms. Fig. S2 shows the effect of EDIN on HUVECs expressing GFP-
  actin. Fig. S3 shows the interference of EDIN on thrombin-induced increase 
of monolayer permeability. Fig. S4 is a characterization of S25-derived 
S.   aureus strains. Video 1 shows endothelial cell intoxication by EDIN. 
Video 2 shows EDIN intoxication of HUVECs expressing GFP-caveolin1. 
Video 3 shows VERO cell intoxication by EDIN. Video 4 shows endothelial 
cell intoxication by C3-exoenzyme of C. botulinum. Video 5 shows actin dy-
namics in rhoA RNAi transfected HUVECs. Video 6 shows actin dynamics 
in EDIN-intoxicated endothelial cells. Video 7 shows HUVEC intoxication 
by toxin-B of C. difﬁ  cile. Video 8 shows the effect of EDIN on endothelial 
cells expressing VE-cadherin–GFP and RFP-actin in the monolayer. Video 9 
shows the effect of EDIN on the endothelial cell monolayer. Video 10 shows 
HUVEC infection by S. aureus. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200509009/DC1.
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